💊DEA Revokes Registration of Empire and Skyline Pharmacies for Violations
The Drug Enforcement Administration issued an Order to Show Cause and Immediate Suspension of Registrations to Empire Pharmacy Inc. and Skyline Pharmacy Inc. for alleged violations concerning recordkeeping and dispensing of controlled substances. The order indicates potential revocation of their registration, deeming their operations inconsistent with public safety and legal standards.
Learn More⚖️DEA Denies Moustafa Aboshady's Registration Application
The Drug Enforcement Administration (DEA) issued an Order to Show Cause, proposing the denial of Dr. Moustafa M. Aboshady's DEA registration application. The basis for this denial stems from his mandatory exclusion from Medicare, Medicaid, and all Federal health care programs due to previous legal convictions related to false statements in healthcare benefits programs. The Agency concluded that substantial evidence supported the denial of his application for registration.
Learn More⚖️DEA Revokes Registration of Victor Augusto Silva, M.D.
The Drug Enforcement Administration has revoked the registration of Dr. Victor Augusto Silva due to violations that allowed an unauthorized individual to prescribe controlled substances. This decision underscores the strict compliance required under federal and Florida laws regarding the use of DEA registrations and the serious implications of non-compliance for medical practitioners.
Learn More⚖️DEA Revocation of Registration
The Drug Enforcement Administration (DEA) revoked Ajumobi Agu, M.D.'s registration due to sustained illegal activity, including dispensing controlled substances without appropriate licenses. The order emphasizes the importance of compliance with both federal and state laws in the healthcare field, and the potential consequences for practitioners engaged in similar misconduct.
Learn More📄Correction Notice from the U.S. Department of Justice – April 2025
The U.S. Department of Justice issued a clarification for "Decision and Order" concerning Phong H. Tran, M.D. The notice corrects a publication error in the Federal Register, explicitly specifying a date to replace placeholders in previously published information. This ensures accuracy in regulatory documentation.
Learn More⚖️DEA Revocation Order Impacts Healthcare Business Compliance
The Drug Enforcement Administration (DEA) issued an Order to Show Cause proposing to revoke the registration of Mary Massullo, D.O. due to her lack of authority to handle controlled substances in Ohio, following the permanent revocation of her medical license. The decision emphasizes the importance of compliance with state regulations for medical practitioners and organizations involved in controlled substance handling.
Learn More🚫Analysis of Baijes Bissonnet Pharmacy DEA Registration Denial
The Drug Enforcement Administration issued a denial notice to Baijes Bissonnet Pharmacy, highlighting significant compliance failures related to controlled substances. The notice outlines allegations of neglecting red flags indicating prescription abuse and diversion, leading to substantial legal risks and regulatory consequences for the pharmacy.
Learn More💊Notice of Application for Bulk Manufacturing by Promega Corporation
Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More🚫DEA Revocation Order for Dr. Thomas Andr'e Endicott, D.D.S.
The Drug Enforcement Administration has revoked the DEA registration of Thomas Andr'e Endicott, D.D.S., due to the revocation of his dental and controlled substance licenses in Utah. This decision highlights the necessity for practitioners to maintain state licensing to uphold their DEA registrations, emphasizing regulatory compliance in the healthcare field.
Learn More⚖️Restek Corporation's Import Application for Controlled Substances Notice
Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Learn More